PDSB
Price:
$2.93
Market Cap:
$107.88M
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related prot...[Read more]
Industry
Biotechnology
IPO Date
2015-09-30
Stock Exchange
NASDAQ
Ticker
PDSB
According to PDS Biotechnology Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 74.53M. This represents a change of -29.92% compared to the average of 106.35M of the last 4 quarters.
The mean historical Enterprise Value of PDS Biotechnology Corporation over the last ten years is 119.26M. The current 74.53M Enterprise Value has changed 6.15% with respect to the historical average. Over the past ten years (40 quarters), PDSB's Enterprise Value was at its highest in in the September 2021 quarter at 354.32M. The Enterprise Value was at its lowest in in the March 2020 quarter at -13518345.23.
Average
119.26M
Median
131.85M
Minimum
-24586815.64
Maximum
327.16M
Discovering the peaks and valleys of PDS Biotechnology Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.77%
Maximum Annual Enterprise Value = 327.16M
Minimum Annual Increase = -1232.04%
Minimum Annual Enterprise Value = -24586815.64
Year | Enterprise Value | Change |
---|---|---|
2023 | 121.12M | -62.98% |
2022 | 327.16M | 129.45% |
2021 | 142.58M | 1.77% |
2020 | 7.61M | 929.56% |
2019 | 738.67K | -103.00% |
2018 | -24586815.64 | -111.32% |
2017 | 217.18M | -19.37% |
2016 | 269.36M | -1232.04% |
2015 | -23793887.00 | -115.33% |
2014 | 155.24M | -1.94% |
The current Enterprise Value of PDS Biotechnology Corporation (PDSB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
196.96M
5-year avg
119.84M
10-year avg
119.26M
PDS Biotechnology Corporation’s Enterprise Value is less than Mereo BioPharma Group plc (0), less than Terns Pharmaceuticals, Inc. (582.99M), less than Inozyme Pharma, Inc. (458.36M), less than HOOKIPA Pharma Inc. (343.89M), less than eFFECTOR Therapeutics, Inc. (87.25M), greater than Enveric Biosciences, Inc. (3.83M), greater than CohBar, Inc. (1.02M), greater than Ocean Biomedical, Inc. (-4942363.00), greater than AVROBIO, Inc. (44.98M), greater than X4 Pharmaceuticals, Inc. (-85302404.00), greater than Day One Biopharmaceuticals, Inc. (40.79M), less than Elevation Oncology, Inc. (1.01B), greater than null (8.41M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $664.26M | |
582.99M | $549.60M | |
458.36M | $312.42M | |
343.89M | $159.50M | |
87.25M | $188.18K | |
3.83M | $4.53M | |
1.02M | $1.25M | |
-4942363.00 | $33.96M | |
44.98M | $5.24M | |
-85302404.00 | $109.78M | |
40.79M | $1.25B | |
1.01B | $36.94M | |
8.41M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PDS Biotechnology Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PDS Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is PDS Biotechnology Corporation's Enterprise Value?
What is the highest Enterprise Value for PDS Biotechnology Corporation (PDSB)?
What is the 3-year average Enterprise Value for PDS Biotechnology Corporation (PDSB)?
What is the 5-year average Enterprise Value for PDS Biotechnology Corporation (PDSB)?
How does the current Enterprise Value for PDS Biotechnology Corporation (PDSB) compare to its historical average?